EUVIMEDEUVIMED entdecken
Crossref

Association of Immunomodulatory Treatment with Long-Term Visual Outcomes in Behçet Uveitis: A Single-Center Retrospective Study

Seong Taek Woo, Jin-Seok Seo, Yong Wun Cho, Gyu Nam Kim, Seong-Jae Kim, Seong-Wook Seo, Inyoung Chung, Woong-Sun Yoo

Korean Journal of Ophthalmology · 09.11.2026

DOI: 10.3341/kjo.2026.0082 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Korean Journal of Ophthalmology, online erschienen am 09.11.2026. Verfasst von Seong Taek Woo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, College of Medicine, Gyeongsang National University, Gyeongsang National University Hospital, Jinju, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To describe clinical characteristics and treatment patterns in Behçet disease-associated uveitis at a tertiary center and to explore the association between immunomodulatory treatment (IMT) and long-term visual outcomes.

Methods

This single-center retrospective study included adults diagnosed with Behçet disease-associated uveitis/retinal vasculitis. Demographics, anatomical uveitis classification, ocular inflammatory grades, logMAR best-corrected visual acuity (BCVA), complications, surgeries, and systemic therapies were extracted from medical records. Overall ocular outcomes were summarized at the affected-eye level. Comparative analyses according to IMT exposure were performed at the patient level using one eye per patient; in bilateral cases, the eye with worse baseline logMAR BCVA was selected. IMT exposure was defined as documented use of antimetabolite therapy, a T-cell inhibitor, or a TNF-α inhibitor during follow-up. Group comparisons and multivariable analyses were exploratory.

Results

Thirty patients were included (66.7% male; mean age 39.5 ± 11.9 years). Panuveitis was the most common anatomical subtype (56.7%). A total of 42 affected eyes were analyzed descriptively. Mean logMAR BCVA changed from 0.613 ± 0.935 at baseline to 0.894 ± 1.158 at final follow-up. Systemic therapy included oral prednisone in 73.3% of patients, antimetabolite therapy in 40.0%, a T-cell inhibitor in 20.0%, and a TNF-α inhibitor in 13.3%. In patient-level analyses, 13 patients had IMT exposure and 17 did not. Final logMAR BCVA was lower in the IMT-exposed group than in the non-exposed group (0.587 ± 0.870 vs. 1.498 ± 1.303, p=0.050). In an exploratory multivariable linear regression model adjusted for baseline logMAR BCVA, age at visit, and panuveitis, IMT exposure was associated with lower final logMAR BCVA (coefficient, -1.192; 95% CI, -2.131 to -0.253; p=0.015).

Conclusions

In this Korean tertiary-center cohort, Behçet uveitis commonly involved panuveitis with substantial long-term visual morbidity and surgical burden despite systemic therapy. IMT exposure showed a favorable association with final logMAR BCVA in patient-level analyses, although causal inference is limited by the retrospective design and potential confounding. Larger multicenter studies with standardized activity, relapse, and treatment-exposure metrics are warranted.

Schlagwörter

Stichwörter der Autor:innen

Behçet diseaseimmunomodulatory treatmentretinal vasculitisuveitis

Autor:innen und Institutionen

  • Department of Ophthalmology, College of Medicine, Gyeongsang National University, Gyeongsang National University Hospital, Jinju, Republic of Korea.
  • Department of Ophthalmology, College of Medicine, Gyeongsang National University, Gyeongsang National University Hospital, Jinju, Republic of Korea. wsyoo0519@gmail.com.

Zitieren

APA

Woo, S. T., Seo, J. S., Cho, Y. W., Kim, G. N., Kim, S. J., Seo, S. W., Chung, I., & Yoo, W. S. (2026). Association of Immunomodulatory Treatment with Long-Term Visual Outcomes in Behçet Uveitis: A Single-Center Retrospective Study. Korean Journal of Ophthalmology. https://doi.org/10.3341/kjo.2026.0082

Vancouver

Woo ST, Seo JS, Cho YW, Kim GN, Kim SJ, Seo SW, et al. Association of Immunomodulatory Treatment with Long-Term Visual Outcomes in Behçet Uveitis: A Single-Center Retrospective Study. Korean Journal of Ophthalmology. 2026. doi:10.3341/kjo.2026.0082

BibTeX
@article{Woo2026,
  author = {Woo, Seong Taek and Seo, Jin-Seok and Cho, Yong Wun and Kim, Gyu Nam and Kim, Seong-Jae and Seo, Seong-Wook and Chung, Inyoung and Yoo, Woong-Sun},
  title = {Association of Immunomodulatory Treatment with Long-Term Visual Outcomes in Behçet Uveitis: A Single-Center Retrospective Study},
  journal = {Korean Journal of Ophthalmology},
  year = {2026},
  doi = {10.3341/kjo.2026.0082}
}
Kostenlos starten →